|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5739018A
(en)
|
1996-08-07 |
1998-04-14 |
The Regents Of The University Of California |
Packaging cell lines for pseudotyped retroviral vectors
|
|
US6207455B1
(en)
|
1997-05-01 |
2001-03-27 |
Lung-Ji Chang |
Lentiviral vectors
|
|
EP0981636B1
(en)
|
1997-05-13 |
2005-03-23 |
University Of North Carolina At Chapel Hill |
Lentivirus-based gene transfer vectors
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
JP2002538842A
(ja)
|
1999-03-16 |
2002-11-19 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
大量のスクリーニングのためのレンチウイルスベクター系
|
|
WO2001027304A2
(en)
|
1999-10-12 |
2001-04-19 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US7135339B2
(en)
|
2003-11-20 |
2006-11-14 |
University Of Iowa Research Foundation |
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
|
|
EP1769078A1
(en)
|
2004-07-01 |
2007-04-04 |
VIRxSYS Corporation |
Vector packaging cell line
|
|
JP2006085744A
(ja)
|
2004-09-14 |
2006-03-30 |
Matsushita Electric Ind Co Ltd |
磁気記録再生装置及びそのテープスレッディング方法
|
|
WO2007095201A2
(en)
|
2006-02-15 |
2007-08-23 |
The Regents Of The University Of California |
Pseudotyped retroviral vectors and methods of use thereof
|
|
AU2007248019B2
(en)
|
2006-05-03 |
2012-10-11 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Chimeric T cell receptors and related materials and methods of use
|
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
|
US9273283B2
(en)
*
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
GB0920775D0
(en)
|
2009-11-26 |
2010-01-13 |
King S College |
Cells
|
|
EP2895203A4
(en)
|
2012-06-15 |
2016-09-28 |
Imaginab Inc |
ANTIGENBINDING CONSTRUCTS FOR CD3
|
|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP3027204B1
(en)
|
2013-07-29 |
2022-01-05 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
EP3087101B1
(en)
*
|
2013-12-20 |
2024-06-05 |
Novartis AG |
Regulatable chimeric antigen receptor
|
|
US20170081411A1
(en)
|
2014-03-15 |
2017-03-23 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
DK3166968T3
(da)
|
2014-05-02 |
2021-12-06 |
Univ Pennsylvania |
Sammensætninger og fremgangsmåder til kimæriske autoantistofreceptor-T-celler
|
|
GB201412494D0
(en)
*
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
EP3511413B1
(en)
*
|
2014-07-25 |
2022-09-07 |
Theravectys |
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
|
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
|
US20180127781A1
(en)
|
2015-01-21 |
2018-05-10 |
Fred Hutchinson Cancer Research Center |
Cocal envelope pseudotyped retroviral vector producer cells
|
|
EP3261651B1
(en)
|
2015-02-27 |
2022-05-04 |
iCell Gene Therapeutics LLC |
Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
|
|
GB201503500D0
(en)
|
2015-03-02 |
2015-04-15 |
Ucl Business Plc |
Cell
|
|
WO2016147182A1
(en)
*
|
2015-03-16 |
2016-09-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Isolated peptides derived from the b7 ligand dimer interface and uses thereof
|
|
WO2017015427A1
(en)
*
|
2015-07-21 |
2017-01-26 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
GB201514875D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
|
CN108884460B
(zh)
|
2016-03-19 |
2023-04-28 |
埃克苏马生物技术公司 |
淋巴细胞转导及其扩增调节的方法与组合物
|
|
US12144850B2
(en)
|
2016-04-08 |
2024-11-19 |
Purdue Research Foundation |
Methods and compositions for car T cell therapy
|
|
EP3458485B1
(en)
|
2016-05-19 |
2021-12-29 |
The General Hospital Corporation |
Tethered interleukin-2 to its receptor il-2rbeta, a platform to enhance natural killer and regulatory t cell activity
|
|
EP3512540A1
(en)
|
2016-09-14 |
2019-07-24 |
Université Catholique de Louvain |
Modified vsv-g and vaccines thereof
|
|
CN118546256A
(zh)
|
2016-12-13 |
2024-08-27 |
西雅图儿童医院（Dba西雅图儿童研究所） |
在体外和体内对工程化的细胞中表达的化学物质诱导的信号传导复合物进行外源性药物激活的方法
|
|
WO2018132508A1
(en)
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Methods and compositions relating to ex vivo culture and modulation of t cells
|
|
AU2018219226B2
(en)
|
2017-02-07 |
2024-12-19 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
CN118634339B
(zh)
|
2017-02-17 |
2025-07-01 |
珀杜研究基金会 |
用于细胞疗法的基于靶向性配体-有效负载的药物递送
|
|
ES3010559T3
(en)
|
2017-02-28 |
2025-04-03 |
Endocyte Inc |
Compositions and methods for car t cell therapy
|
|
CN111479921B
(zh)
|
2017-09-18 |
2024-08-02 |
埃克苏马生物技术公司 |
用于以基因方式修饰且扩增淋巴细胞以及调节其活性的方法及组合物
|
|
US20210093637A1
(en)
|
2017-12-07 |
2021-04-01 |
Dermavant Sciences GmbH |
Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
WO2019156795A1
(en)
|
2018-02-06 |
2019-08-15 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
WO2019157533A1
(en)
|
2018-02-12 |
2019-08-15 |
The General Hospital Corporation |
Chimeric antigen receptors targeting the tumor microenvironment
|
|
CN112262214A
(zh)
|
2018-04-12 |
2021-01-22 |
优莫佳生物制药股份有限公司 |
病毒载体及包装细胞系
|
|
CA3108778A1
(en)
|
2018-08-06 |
2020-02-13 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells
|
|
SG11202100616VA
(en)
|
2018-08-07 |
2021-03-30 |
Purdue Research Foundation |
Rejuvenation of car t cell
|
|
WO2020106992A1
(en)
|
2018-11-21 |
2020-05-28 |
Umoja Biopharma, Inc. |
Multicistronic vector for surface engineering lentiviral particles
|
|
SG11202105380RA
(en)
|
2018-11-30 |
2021-06-29 |
Juno Therapeutics Inc |
Methods for dosing and treatment of b cell malignancies in adoptive cell therapy
|
|
CA3154281A1
(en)
|
2019-10-16 |
2021-04-22 |
Andrew Scharenberg |
Retroviral vector for universal receptor therapy
|
|
US12540336B2
(en)
|
2020-05-27 |
2026-02-03 |
The Medical College Of Wisconsin, Inc. |
Lentiviral vector transfer plasmid and methods of use
|
|
US11517814B2
(en)
|
2020-09-03 |
2022-12-06 |
Alan Chalmers |
Flavour system
|
|
JP2023551220A
(ja)
|
2020-11-20 |
2023-12-07 |
ウモジャ バイオファーマ インコーポレイテッド |
複数のポリヌクレオチドを送達するためのベクター系およびその使用法
|
|
MX2023008831A
(es)
|
2021-01-27 |
2023-10-19 |
Umoja Biopharma Inc |
Lentivirus para generar células que expresan receptores de antígeno quimérico anti-cd19.
|
|
AU2023265993A1
(en)
|
2022-05-06 |
2024-10-31 |
Umoja Biopharma, Inc. |
Viral particle with surface stimulating molecules
|